Home » Blog » The Landscape for the Consumer Seems to be Riddled with Land Mines; Increased Premiums, Questionable Practices, and More

The Landscape for the Consumer Seems to be Riddled with Land Mines; Increased Premiums, Questionable Practices, and More


IP Blog | Dave Melin | September 5, 2016

BioBlog WeeklyIn this week’s BioBlog we explore articles addressing sketchy practices by PBMs, the Cancer Moonshot’s impact on developing countries, premium hikes in Minnesota and ethical questions for drug companies.

Pharmacy Benefit Managers Improperly Reinterpret Medicare Rules for Financial Gain

After decades of classifying and paying claims for physician dispensing as “in-network,” the PBMs are playing a dangerous game with patient care in order to capture revenue in the growing specialty drug market.

The Developing World Needs A Cancer Moonshot

Patients in the developing world are much more likely to be diagnosed at an advanced stage and die from cancer compared to patients in the United States and other wealthy countries.

Minnesota Health Insurers Propose Big Premium Hikes for Individual Plans

“Once again, families who were told they would save $500 per year will instead see their health plans get more expensive,” said House Speaker Kurt Daudt, R-Crown, in a statement.

Think EpiPen Is Mylan’s First Scandal? Here’s a Timeline of Jet Use, an Unearned MBA and More

This article from Fierce Pharma outlines one company’s troubled past.

Clovis Oncology Speeds Toward Possible Launch in Ovarian Cancer, but Red Flags Remain

The drug is designated for treatment of women with advanced, mutant (inclusive of both germline and somatic BRCA mutations ) ovarian cancer.


Topics in this Post:



Leave a Comment

Your email address will not be published. Required fields are marked *